Floatz logo

IRON SUCCINATE (FE(O4C4H4))

Transient Ischemic Attack

Beijing Tiantan HospitalSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

21 Active assets in the Transient Ischemic Attack cohort.

Asset / SponsorPhaseRating
Plavix
Sichuan Provincial People's Hospital
Phase 4BBB
Acetylsalicylic Acid
Sichuan Provincial People's Hospital
Phase 4BBB
Ticagrelor
Mazandaran University of Medical Sciences
Phase 3BBB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Stanford University
Phase 4BBB
Rivaroxaban
General Hospital of Shenyang Military Region
Phase 4BBB

View all 42 →

Same molecule, other indications

IRON SUCCINATE (FE(O4C4H4)) is also rated in:

Hematopoietic Stem Cell TransplantationDormant
BB
Indicative ·
65 / 100
View asset →
AnemiaDormant
BB
Indicative ·
65 / 100
View asset →
Phenylketonuria (PKU)Dormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →